Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-05-05 @ 12:25 AM
Study NCT ID:
NCT00541658
Status:
COMPLETED
Last Update Posted:
2013-04-22
First Post:
2007-10-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
Sponsor:
Warner Chilcott
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Postmenopausal Osteoporosis | View |
Keywords: